APA (7th ed.) Citation

Dongqing Pu, Yue Wu, Debo Xu, Guangxi Shi, Hanhan Chen, Dandan Feng, . . . Jingwei Li. (2024). The adverse events of CDK4/6 inhibitors for HR+/ HER2- breast cancer: An umbrella review of meta-analyses of randomized controlled trials. Frontiers Media S.A..

Chicago Style (17th ed.) Citation

Dongqing Pu, Yue Wu, Debo Xu, Guangxi Shi, Hanhan Chen, Dandan Feng, Mengdi Zhang, and Jingwei Li. The Adverse Events of CDK4/6 Inhibitors for HR+/ HER2- Breast Cancer: An Umbrella Review of Meta-analyses of Randomized Controlled Trials. Frontiers Media S.A., 2024.

MLA (9th ed.) Citation

Dongqing Pu, et al. The Adverse Events of CDK4/6 Inhibitors for HR+/ HER2- Breast Cancer: An Umbrella Review of Meta-analyses of Randomized Controlled Trials. Frontiers Media S.A., 2024.